Walleye Trading LLC Seres Therapeutics, Inc. Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $35,073 - $76,318	15,053 New	15,053 $35,000
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $43,762 - $53,841	8,841 Added 651.51%	10,198 $57,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $6,907 - $12,280	1,357 New	1,357 $7,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $214,257 - $406,805	-35,591 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $133,693 - $553,383	24,486 Added 220.5%	35,591 $248,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $204,998 - $270,517	11,105 New	11,105 $265,000
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $1.09 Million - $1.77 Million	-46,787 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $174,983 - $1.34 Million	46,787 New	46,787 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $61,568 - $111,845	-26,886 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $61,300 - $197,612	26,886 New	26,886 $87,000
Q4 2018 Feb 14, 2019	SELL	$4.52 - $8.88 $451 - $888	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.33 - $9.23 $733 - $923	100 New	100 $1,000

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.